Center-Authored Papers

Filters: Author is Sullivan, Sean D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Washington
Sullivan SD, Ramsey SD, Blough DK, McDermott CL, Clarke L, McCune JS.  2011.  Health care use and primary prophylaxis with colony-stimulating factors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(2):247-52. Abstract
Ramsey SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL, Sullivan SD.  2010.  Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86. Abstract
United States
Sullivan SD, Watkins J, Sweet B, Ramsey SD.  2009.  Health technology assessment in health-care decisions in the United States.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12 Suppl 2:S39-44.
Ramsey SD, Sullivan SD, Kaplan RM.  2008.  Cost-effectiveness of lung volume reduction surgery.. Proceedings of the American Thoracic Society. 5(4):406-11. Abstract
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Ramsey SD, Blough DK, Sullivan SD.  2008.  A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.. Medical care. 46(5):542-8. Abstract
Technology Assessment, Biomedical
Sullivan SD, Watkins J, Sweet B, Ramsey SD.  2009.  Health technology assessment in health-care decisions in the United States.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12 Suppl 2:S39-44.
Survival Analysis
Ramsey SD, Blough DK, Sullivan SD.  2008.  A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.. Medical care. 46(5):542-8. Abstract
Sulfonamides
Hansen RN, Hackshaw MD, Sullivan SD, Ramsey SD.  2015.  The Authors Respond.. Journal of managed care & specialty pharmacy. 21(9):844.
Shared Resources
Ramsey SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL, Sullivan SD.  2010.  Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86. Abstract
September 2013
Gold LS, Buist DSM, Loggers ET, Etzioni R, Kessler L, Ramsey SD, Sullivan SD.  2013.  Advanced diagnostic breast cancer imaging: variation and patterns of care in washington state.. Journal of oncology practice / American Society of Clinical Oncology. 9(5):e194-202. Abstract
SEER Program
Sullivan SD, Ramsey SD, Blough DK, McDermott CL, Clarke L, McCune JS.  2011.  Health care use and primary prophylaxis with colony-stimulating factors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(2):247-52. Abstract
Ramsey SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL, Sullivan SD.  2010.  Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86. Abstract
Secondary Prevention
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Risk Reduction Behavior
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Risk Factors
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Risk Assessment
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
RISK
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Retrospective Studies
Sullivan SD, Ramsey SD, Blough DK, McDermott CL, Clarke L, McCune JS.  2011.  Health care use and primary prophylaxis with colony-stimulating factors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(2):247-52. Abstract
Ramsey SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL, Sullivan SD.  2010.  Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86. Abstract
Randomized Controlled Trials as Topic
Ramsey SD, Blough DK, Sullivan SD.  2008.  A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.. Medical care. 46(5):542-8. Abstract
Blough DK, Ramsey SD, Sullivan SD, Yusen R.  2009.  The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery.. Health economics. 18(1):91-101. Abstract
Ramsey SD, Sullivan SD, Kaplan RM.  2008.  Cost-effectiveness of lung volume reduction surgery.. Proceedings of the American Thoracic Society. 5(4):406-11. Abstract
Quality-Adjusted Life Years
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Ramsey SD, Blough DK, Sullivan SD.  2008.  A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.. Medical care. 46(5):542-8. Abstract